Vynleads (VYND) Share-based Compensation (2020)
Vynleads (VYND) reported Share-based Compensation of $11306.0 for Q4 2020, up 20089.29% on a QoQ basis from $56.0 in Q3 2020.
Vynleads (VYND) has 1 years of Share-based Compensation data on file, last reported at $11306.0 in Q4 2020.
- Quarterly Share-based Compensation changed N/A year-over-year to $11306.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $11306.0 (changed N/A YoY) and the FY2020 annual result came in at $39599.0, changed N/A from the prior year.
- Share-based Compensation advanced to $11306.0 in Q4 2020 per VYND's latest filing, from $56.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $19911.0 in Q2 2020 and bottomed at $56.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 118.26 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.68 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 19.41 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 11.69 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 36.74 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 11.45 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 22.64 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 21.92 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 9.50 Mn |
| 10 | Vynleads | - | - | -2,028.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 11,306.00 |
| Dec 31, 2020 | 11,306.00 |
| Sep 30, 2020 | 56.00 |
| Sep 30, 2020 | 56.00 |
| Jun 30, 2020 | 19,911.00 |
| Jun 30, 2020 | 19,911.00 |
| Mar 31, 2020 | 56.00 |
| Mar 31, 2020 | 56.00 |